SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-298219
Filing Date
2020-11-19
Accepted
2020-11-19 16:58:01
Documents
14
Period of Report
2020-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d73587d8k.htm   iXBRL 8-K 25227
2 EX-99.1 d73587dex991.htm EX-99.1 11456
6 GRAPHIC g73587g1119200952580.jpg GRAPHIC 3599
  Complete submission text file 0001193125-20-298219.txt   169209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bxrx-20201119.xsd EX-101.SCH 3079
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bxrx-20201119_lab.xml EX-101.LAB 18123
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bxrx-20201119_pre.xml EX-101.PRE 11411
7 EXTRACTED XBRL INSTANCE DOCUMENT d73587d8k_htm.xml XML 3374
Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address 490 LAPP ROAD MALVERN PA 19355 484-395-2470
Baudax Bio, Inc. (Filer) CIK: 0001780097 (see all company filings)

IRS No.: 474639500 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39101 | Film No.: 201329440
SIC: 8090 Services-Misc Health & Allied Services, NEC